Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy
US6432992B1 · kind B1 · utility
5Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 5, 2001 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Jun 5, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/428
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of riluzole or one of its pharmaceutically acceptable salts for the prevention and treatment of adrenoleukodystrophy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.